156 related articles for article (PubMed ID: 17437125)
21. Acute angle closure following hemodialysis in a 34-year-old Nigerian female.
Olawoye OO; Ogunleye T; Sarimiye TF; Bello TO
Niger J Clin Pract; 2018 Jul; 21(7):942-944. PubMed ID: 29984730
[TBL] [Abstract][Full Text] [Related]
22. [Long-term outcomes of laser peripheral iridectomy for primary angle closure glaucoma].
Bian AL; Zhao JL; Zhou Q; Zhang Y; Liu XL; Mao J
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1099-104. PubMed ID: 20193433
[TBL] [Abstract][Full Text] [Related]
23. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
24. Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma.
Teekhasaenee C; Ritch R
Ophthalmology; 1999 Apr; 106(4):669-74; discussion 674-5. PubMed ID: 10201585
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and risk factors for primary glaucomas in adult urban and rural populations in the Andhra Pradesh Eye Disease Study.
Garudadri C; Senthil S; Khanna RC; Sannapaneni K; Rao HB
Ophthalmology; 2010 Jul; 117(7):1352-9. PubMed ID: 20188420
[TBL] [Abstract][Full Text] [Related]
26. Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.
Kim GN; Han YS; Chung IY; Seo SW; Park JM; Yoo JM
Semin Ophthalmol; 2013 Mar; 28(2):61-7. PubMed ID: 23448557
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study.
Kook MS; Cho HS; Yang SJ; Kim S; Chung J
J Ocul Pharmacol Ther; 2005 Feb; 21(1):75-84. PubMed ID: 15718831
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of Ocusert Pilo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment of primary acute angle-closure glaucoma.
Edwards RS
Curr Med Res Opin; 1997; 13(9):501-9. PubMed ID: 9169252
[TBL] [Abstract][Full Text] [Related]
29. Angle closure in the Andhra Pradesh Eye Disease Study.
Senthil S; Garudadri C; Khanna RC; Sannapaneni K
Ophthalmology; 2010 Sep; 117(9):1729-35. PubMed ID: 20466426
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of primary angle closure and primary angle-closure glaucoma in a southwestern rural population of Japan: the Kumejima Study.
Sawaguchi S; Sakai H; Iwase A; Yamamoto T; Abe H; Tomita G; Tomidokoro A; Araie M
Ophthalmology; 2012 Jun; 119(6):1134-42. PubMed ID: 22361313
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
32. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC
Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
[TBL] [Abstract][Full Text] [Related]
33. Anterior chamber paracentesis in patients with acute elevation of intraocular pressure.
Arnavielle S; Creuzot-Garcher C; Bron AM
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):345-50. PubMed ID: 17111147
[TBL] [Abstract][Full Text] [Related]
34. The Singapore 5-fluorouracil trial: intraocular pressure outcomes at 8 years.
Wong MH; Husain R; Ang BC; Gazzard G; Foster PJ; Htoon HM; Wong TT; Oen FT; Khaw PT; Seah SK; Aung T
Ophthalmology; 2013 Jun; 120(6):1127-34. PubMed ID: 23466269
[TBL] [Abstract][Full Text] [Related]
35. Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma.
Aung T; Lim MC; Chan YH; Rojanapongpun P; Chew PT;
Ophthalmology; 2005 Jan; 112(1):28-32. PubMed ID: 15629816
[TBL] [Abstract][Full Text] [Related]
36. A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma.
Metheetrairut A; Leumsamran P; Rojananin S; Kitnarong N
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S116-22. PubMed ID: 22696863
[TBL] [Abstract][Full Text] [Related]
37. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
Sakai H; Shinjyo S; Nakamura Y; Nakamura Y; Ishikawa S; Sawaguchi S
J Ocul Pharmacol Ther; 2005 Dec; 21(6):483-9. PubMed ID: 16386090
[TBL] [Abstract][Full Text] [Related]
38. Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy.
Husain R; Gazzard G; Aung T; Chen Y; Padmanabhan V; Oen FT; Seah SK; Hoh ST
Ophthalmology; 2012 Nov; 119(11):2274-81. PubMed ID: 22885123
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
Chen MJ; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
[TBL] [Abstract][Full Text] [Related]
40. Anterior segment morphology after acute primary angle closure treatment: a randomised study comparing iridoplasty and medical therapy.
Sng CC; Aquino MC; Liao J; Zheng C; Ang M; Chew PT
Br J Ophthalmol; 2016 Apr; 100(4):542-8. PubMed ID: 26294102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
